Besch Doug 4
4 · OptimizeRx Corp · Filed Oct 7, 2024
Insider Transaction Report
Form 4
OptimizeRx CorpOPRX
Besch Doug
Chief Product Officer
Transactions
- Exercise/Conversion
Common Stock
2024-10-03+3,324→ 11,172 total - Tax Payment
Common Stock
2024-10-03$7.83/sh−976$7,642→ 10,196 total - Exercise/Conversion
Restricted Stock Units
2024-10-03−3,324→ 3,325 total→ Common Stock (3,324 underlying)
Footnotes (3)
- [F1]Restricted stock units convert into common stock on a one-for-one basis.
- [F2]These shares were withheld by the Issuer to satisfy the Reporting Person's tax withholding obligations. Such withholding is treated as a disposition of securities under Section 16 of the Securities Exchange Act of 1934, as amended.
- [F3]The restricted stock units vest in three equal annual installments beginning October 3, 2023, the first anniversary of the grant date.